上海
分享至
亚太药业公告，公司注射用头孢唑肟钠近日收到国家药品监督管理局核准签发的《药品补充申请批准通知书》。该药品增加了2.0g和0.5g规格，并通过仿制药质量和疗效一致性评价。
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
